Oral or Injectable composition is provided, for treating the disease as caused by retrovirus or hepatitis type B virus. The composition includes at least one antiretroviral drugs of therapeutically effective amount and at least one pharmacokinetics synergist of therapeutically effective amount or reinforcing agent or derivatives thereof. Additionally provide method and kit.